Summary
There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use disorder taking semaglutide or liraglutide had a decreased risk of hospitalization for alcohol or other substance use.
Source: The Detroit News
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
